Clinical Trial Update: Clinical Trial in Chinese Patients of B-cell Non-Hodgkin's Lymphoma(GB226) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for GB226 in Chinese patients with B-cell non-Hodgkin's lymphoma is reported; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma

Drugs mentioned

• GB226

Snippet

Sponsor: Genor Biopharma Co., Ltd. | Conditions: B-cell Non-Hodgkin's Lymphoma | Phase 2 | Status: UNKNOWN